SpaceX retail demand reportedly reaches $100B as historic IPO nears Ivar AI

BusinessLine

SpaceX IPO pushes Elon Musk’s net worth past $1 trillion

KQED

SpaceX Blasts Off With a Record-Breaking $75 Billion IPO

The Times of India

US stocks: SpaceX to make historic listing on Nasdaq on Friday that could make Elon Musk a trillionaire

The Times of India

'The Donald of Dubai': UAE billionaire close to Trump bets $66 billion on AI to become the world's data king

Abril.com.br

SpaceX estreia na Bolsa com IPO recorde de US$ 75 bilhões

CNN

OpenAI files for IPO | CNN Business

Diariobitcoin.com

EE. UU. ataca Irán tras caída de helicóptero estadounidense frente a Omán

El Financiero

Histórico ‘despegue’ para SpaceX: Recauda 75 mil mdd tras debutar en bolsa y dispara la fortuna de Musk

SiliconANGLE News

Neura Robotics to raise up to $1.4B from Nvidia-backed consortium

Crypto Briefing

Iran’s Khatam al-Anbiya Central Headquarters orders Strait of Hormuz closed to oil tankers

CNBC

From startup to $1.8 trillion: The investors who took a chance on SpaceX now reap the rewards

TechRadar

This Microsoft Defender zero-day could give hackers unprecedented access to your system

Businessam.be

Italiaanse bank Intesa Sanpaolo kan dankzij overname op één na grootste bank van Europa worden

Crypto Briefing

Iran targets US ships near Strait of Hormuz with missiles and drones

New York Post

ChatGPT maker OpenAI files for IPO looking to capitalize on investor appetite for AI boom

CBS News

How to buy SpaceX shares as its blockbuster IPO readies for liftoff

Yahoo Entertainment

美國會遏阻伊朗無人機技術中東衝突升級油價飆漲

Elconfidencialdigital.com

BlackRock ve una oportunidad única en el espacio y lanza un ETF para aprovecharla

Forbes

Global AI Buildout Proves Wealth Lode For Its Picks-And-Shovels Billionaires In Taiwan

N-tv.de

Nach Hubschrauber-Abschuss: "Selbstverteidigung": US-Militär fliegt neue Angriffe gegen den Iran

Elconfidencialdigital.com

La salida a Bolsa de OpenAI puede transformar para siempre la inversión en inteligencia artificial

$Cellectis reçoit le statut RMAT de la FDA pour lasmé-cel, la première thérapie CAR-T allogénique en essai pivot pour les patients atteints de LLA-B en rechute ou réfractaire$

GlobeNewswire

Cellectis reçoit le statut RMAT de la FDA pour lasmé-cel, la première thérapie CAR-T allogénique en essai pivot pour les patients atteints de LLA-B en rechute ou réfractaire